Company Information
Last revised: 3 October 2026
Founded by a UK patient within the prescribed medicine pathway. Built from inside the system that failed to provide it.
Registered Details
Company Name: Purus Lumina Ltd
Company Number: 17035897
Registered in: England and Wales
Incorporated: 16 February 2026
Status: Active
Registered Office: 3rd Floor, 86–90 Paul Street, London, EC2A 4NE, England
Companies House: Verifiable at Companies House
Director
Glenn Hailes, Director and Founder. Publicly listed on Companies House.
Intellectual Property
Registered Trade Mark: Purus Lumina®, UK00004341531
All content, trademarks, and materials on this website are the property of Purus Lumina Ltd. Unauthorised reproduction or use is prohibited.
Business Identifiers
D-U-N-S® Number: 234584307: Verifiable at dnb.com
LEI (Legal Entity Identifier): 98450015638FFAAD9A25: Verifiable at GLEIF
GS1 UK Member: Company Prefix 5070004507. GTINs registered across the full Purus Lumina® product range.
Verified by GS1 (VbG): Confirmed ✅ 15 July 2026
GS1 Digital Link: Every product carries a GS1 Digital Link QR code for authenticity and traceability, resolving at id.puruslumina.com
ICO Registration: ZC098765, Data Protection Officer: privacy@puruslumina.com
Manufacturing & Supply Chain
Assembled, sealed, and numbered in Northumberland, at the geographical centre of Great Britain.
The Purus Lumina device-care solution has a UK supply chain from formulation to fulfilment. The authorised Storz & Bickel range is supplied separately by Storz & Bickel and imported into the UK.
Isopropanol shipped in full compliance with UK dangerous goods regulations. Every bottle is securely sealed and packaged for transport.
Product Compliance
CLP Compliant: The Purus Lumina device-care solution is labelled in accordance with the Classification, Labelling and Packaging Regulation (GB CLP).
COSHH Compliant: Storage and handling of the Purus Lumina device-care solution are maintained in accordance with the Control of Substances Hazardous to Health Regulations 2002.
Product Liability Insurance: In place. Policy details available to institutional and wholesale partners on request.
Business Banking
Purus Lumina Ltd maintains business bank accounts for company transactions.
VAT
VAT registration in progress. Registration number will be published here upon confirmation.
Ordering & Supply
Direct-to-patient via puruslumina.com. Monthly supply is arranged by email: contact advisory@puruslumina.com. No contract, cancel anytime, transparent billing, no hidden charges.
Direct clinical and wholesale supply available. Enquiries: medical@puruslumina.com
Education
Publisher of a Medical Cannabis device-care education programme: 21 modules across 5 series, covering clinical duty of care, patient safety, regulatory landscape, and device hygiene standards. Formally submittable to NICE, MHRA, NHS England, and the Home Office as an educational contribution. Available free at puruslumina.com/pages/education.
Institutional Correspondence
On 28 August 2026, Purus Lumina dispatched a coordinated institutional submission to 21 recipients, including NHS England, MHRA, NICE, the Home Office, and the All-Party Parliamentary Group on Drug Policy Reform. The submission addresses the absence of device-care standards within the UK prescribed medicine pathway and presents the domestic infrastructure response. The submission is preserved in the Institutional Record.
Contact
General: hello@puruslumina.com
Advisory: advisory@puruslumina.com
Medical & Wholesale: medical@puruslumina.com
Legal: legal@puruslumina.com
Privacy: privacy@puruslumina.com
Website: www.puruslumina.com
This document is preserved in perpetuity within the records of Purus Lumina Ltd.
Purus Lumina Ltd · 3rd Floor, 86–90 Paul Street · London · EC2A 4NE · Registered in England and Wales